Product Information

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB is a generic product labeled by Edenbridge Pharmaceuticals LLC, priced at $0.2141 per EA under NDC 42799092130. Its NADAC has been published 302 times since Nov 11, 2020.

FDA first approved this application on Jul 9, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB

Bisoprolol Fumarate and Hydrochlorothiazide
$0.2141per EA

Strength

5; 6.25 mg/1; mg/1

NDC

42799092130

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212678

FDA Approved

7/9/2020

TE Code

AB

On Market Since

4/30/2019

Pharmacological Classes

Adrenergic beta-Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides
beta-Adrenergic Blocker

Price Statistics

The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has been published 302 times since Nov 11, 2020, and over the history we have for it it has declined 49.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2141 per EA
All-time high$0.4372 (Dec 16, 2020)
All-time low$0.1467 (Nov 20, 2024)
52-week high$0.2167
52-week low$0.1916
Median price$0.2549
Average price$0.2703
Largest weekly change-32.1% (Nov 20, 2024)
Weeks tracked302
Tracking sinceNov 11, 2020

Price History

1W

-1.2%

1M

-1.2%

3M

+0.3%

6M

+11.7%

1Y

-0.9%

3Y

-18.3%

5Y

-42.1%

All

-49.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB, manufactured by Edenbridge Pharmaceuticals LLC, is $0.2141 per EA (NDC 42799092130), effective Aug 19, 2026.

How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB changed over time?

Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has declined 49.9%. It has been tracked across 302 weekly CMS publications since Nov 11, 2020.

What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

Since Nov 11, 2020, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB has ranged from a low of $0.1467 (Nov 20, 2024) to a high of $0.4372 (Dec 16, 2020), with a median of $0.2549 per EA.

Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB?

BISOPROLOL-HYDROCHLOROTHIAZIDE 5-6.25 MG TAB (NDC 42799092130) is labeled by Edenbridge Pharmaceuticals LLC, and CMS classifies it as a generic product.